BMJ  2007;335:925 (3 November), doi:10.1136/bmj.39343.511389.BE (published 11 October 2007)

Research

Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials

¹ National Heart and Lung Institute, London SW3 6LY, ² Department of Cardiology, Kent and Canterbury Hospital, Canterbury

Objective To review the evidence base from randomised controlled trials of combined cardiac resynchronisation therapy and implantable cardioverter defibrillator therapy in left ventricular impairment and symptomatic heart failure.

Design Bayesian network meta-analysis.

Data sources Medline, Embase, and Cochrane databases up to June 2006.

Review methods Two reviewers independently assessed trial eligibility and quality. Included trials compared cardiac resynchronisation therapy, implantable cardioverter defibrillator therapy, combined resynchronisation and implantable defibrillator therapy, and medical therapy alone, in patients with impaired left ventricular systolic function. Bayesian random effects network models were used to examine overall number of deaths.

Results 12 studies including 1636 events in 8307 patients were identified. Combined cardiac resynchronisation and implantable cardioverter defibrillator therapy reduced the number of deaths by one third compared with medical therapy alone (odds ratio 0.57, 95% credible interval 0.40 to 0.80) but did not further improve survival when compared with implantable defibrillator therapy (0.82, 0.57 to 1.18) or resynchronisation (0.85, 0.60 to 1.22) therapy alone.

Conclusion Evidence from randomised controlled trials is insufficient to show the superiority of combined cardiac resynchronisation and implantable cardioverter defibrillator therapy over cardiac resynchronisation therapy alone in patients with left ventricular impairment.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Device therapy in heart failure

Finlay A McAlister
BMJ 2007 335: 895-896. [Extract] [Full Text] [PDF]

Simultaneous comparison of multiple treatments: combining direct and indirect evidence

Deborah M Caldwell, A E Ades, and J P T Higgins
BMJ 2005 331: 897-900. [Extract] [Full Text] [PDF]

New pacing technologies for heart failure

Anthony W C Chow, Rebecca E Lane, and Martin R Cowie
BMJ 2003 326: 1073-1077. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Lam, S. K.H., Owen, A. (2008). What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure?. Europace 10: 511-511 [Full text]  
• Vardas, P. E., Auricchio, A., Blanc, J.-J., Daubert, J.-C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M. (2008). What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure? reply. Europace 10: 511-512 [Full text]  
• Lam, S. K.H., Owen, A. (2008). What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure?. Eur Heart J 29: 682-683 [Full text]  
• Vardas, P. E., Auricchio, A., Blanc, J.-J., Daubert, J.-C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M. (2008). What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure? reply. Eur Heart J 29: 683-684 [Full text]  
• McAlister, F. A (2007). Device therapy in heart failure. BMJ 335: 895-896 [Full text]  

Rapid Responses:

Read all Rapid Responses

A posteriori confounders to the Bayesian meta-analysis of resynchronisation and implantable defibrillator therapy

Michael Y. Henein, et al.
bmj.com, 23 Oct 2007 [Full text]

ICDs in Heart Failure

Mahmood Ahmad, et al.
bmj.com, 2 Nov 2007 [Full text]